Position in INDV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,928,749
+$2,048,585 QoQ
Shares Held
266,360
-8.6% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. INDV ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,567,388 | $256,352,500 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,916,666 | $132,696,643 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
207,093 | $112,209,199 | |
| 4 | VTRS |
Viatris Inc
|
4,069,647 | $64,625,993 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
314,451 | $52,997,570 | |
| 6 | ALKS |
Alkermes plc.
|
393,524 | $20,620,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
711,233 | $17,503,443 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,012,792 | $15,941,311 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,928,749 | 266,360 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,880,164 | 291,344 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||